How Much Bac Water For Kpv 10mg

Direct Answer: Reconstitution Ratios for KPV 10mg

Reconstituting a 10 mg vial of KPV peptide with 1.0 mL of bacteriostatic water yields a final concentration of 10 mg/mL (100 mcg per 0.01 mL). Reconstituting with 2.0 mL yields 5.0 mg/mL (50 mcg per 0.01 mL), while 5.0 mL of diluent provides a concentration of 2.0 mg/mL (20 mcg per 0.01 mL).

The table below outlines common diluent volumes when using standard bacteriostatic water to prepare a KPV 10mg product vial for benchtop experiments:

• 1.0 mL Diluent = 10.0 mg/mL (10 mcg/µL) — Ideal for concentrated stock solutions and low-volume micro-pipetting. • 2.0 mL Diluent = 5.0 mg/mL (5 mcg/µL) — Standard volumetric balance for ease of measurement in cell culture assays. • 2.5 mL Diluent = 4.0 mg/mL (4 mcg/µL) — Convenient for even-integer dilution series in analytical assays. • 5.0 mL Diluent = 2.0 mg/mL (2 mcg/µL) — Optimal for protocols requiring larger fluid volumes and higher volumetric precision.

Choosing the ideal volume hinges on your laboratory equipment's minimum accurate displacement volume. If your research protocol calls for low-microliter aliquoting, higher concentrations (1.0 mL to 2.0 mL diluent) are typically preferred to minimize storage volume and prevent freeze-thaw degradation of working stocks. For a interactive calculation model, refer to our comprehensive peptide reconstitution calculator.

Chemical Structure and Properties of the KPV Tripeptide

KPV is a C-terminal tripeptide fragment corresponding to amino acids 11 through 13 of alpha-Melanocyte-Stimulating Hormone (alpha-MSH). Composed of the amino acid sequence Lysine-Proline-Valine (Lys-Pro-Val), this short-chain peptide possesses a molecular weight of approximately 383.48 g/mol. Its compact molecular architecture allows for high solubility in aqueous buffers and distinct pharmacokinetic stability compared to parent full-length melanocortin peptides.

Unlike full-length alpha-MSH, KPV lacks the amino acid sequences responsible for binding to melanocortin-1 receptors (MC1R) that induce pigmentary responses. Instead, preclinical literature demonstrates that KPV exerts biological activity independently of classic melanocortin receptor activation, functioning primarily through intracellular transport mechanisms and nuclear factor kappa B (NF-kB) pathway modulation.

To explore the complete biochemical profile and literature summary of this molecule, researchers can review our dedicated KPV peptide research overview.

Preclinical Mechanisms: Inflammatory Pathways and Intestinal Barrier Research

Preclinical studies evaluate KPV primarily as an anti-inflammatory tripeptide with specialized activity within mucosal and epithelial tissues. In vitro assays demonstrate that KPV is transported directly into intestinal epithelial cells via PepT1 (Peptide Transporter 1), an apical membrane transporter upregulated during inflammatory states. Once inside the cell, in vitro data indicate that KPV interacts directly with intracellular signaling cascades to inhibit the translocation of p65 NF-kB into the nucleus.

In rodent models of dextran sulfate sodium (DSS)-induced colitis, KPV administration demonstrated significant reduction in mucosal inflammation, downregulation of pro-inflammatory cytokines (including TNF-alpha, IL-6, and IL-1beta), and preservation of tight-junction protein expression. Research suggests that KPV assists in maintaining intestinal barrier integrity by suppressing inflammatory destruction of claudin and occludin complexes.

Because PepT1 is expressed abundantly throughout the gastrointestinal tract, researchers routinely utilize KPV in cell-culture models (such as Caco-2 monolayers) to evaluate transepithelial electrical resistance (TEER) and inflammatory responses to lipopolysaccharide (LPS) challenge.

Laboratory Reconstitution Protocol for KPV 10mg Vials

Proper laboratory protocol must be maintained during the reconstitution of lyophilized KPV to prevent bacterial contamination, peptide shear stress, or loss of biological activity. All operations should be conducted within a certified laminar flow hood utilizing aseptic technique.

Step 1: Allow the lyophilized KPV 10mg vial to equilibrate to room temperature (20°C to 25°C) before reconstitution. Opening or injecting fluid into a cold vial can cause condensation of ambient atmospheric moisture inside the vessel, altering total solvent volume.

Step 2: Clean the rubber septum of the vial with a fresh 70% isopropyl alcohol swab and permit it to air-dry completely.

Step 3: Using a sterile micro-syringe, draw the exact pre-calculated volume of diluent (e.g., 2.0 mL of bacteriostatic water containing 0.9% benzyl alcohol). Gently introduce the needle through the center of the septum.

Step 4: Aim the diluent stream against the glass sidewall of the vial rather than shooting it directly onto the lyophilized powder cake. This minimizes mechanical stress on the peptide structure.

Step 5: Allow the diluent to fully saturate the lyophilized plug. Gently swirl the vial in a circular motion on the benchtop until the solution is completely clear and colorless. Never shake or vortex lyophilized peptides, as violent agitation can induce aggregation and denature secondary structures.

Solubility, Storage, and Temperature Control Guidelines

Lyophilized KPV exhibits excellent aqueous solubility due to the hydrophilic nature of its basic lysine residue. When reconstituted with bacteriostatic water, the 0.9% benzyl alcohol acts as a bacteriostatic preservative, inhibiting microbial growth during repeated laboratory sampling over extended experiment durations.

Unreconstituted, lyophilized KPV powder should be stored in a freezer at -20°C or -80°C for long-term stability, where it remains stable for up to 24 months. Protect the vial from prolonged exposure to light.

Once reconstituted, working aliquots should be stored under refrigeration at 2°C to 8°C. Under these refrigerated conditions, KPV reconstituted in bacteriostatic water maintains high analytical stability for up to 28 days. If research protocols require longer storage times post-reconstitution, single-use aliquots should be frozen at -80°C to avoid repeated freeze-thaw cycles, which degrade peptide purity over time.

Calculating Working Dilutions for In Vitro Assays

Converting stock reconstituted KPV into working laboratory dilutions requires accurate concentration calculations (C1V1 = C2V2). For instance, if a researcher reconstitutes a 10 mg vial with 2.0 mL of bacteriostatic water, the resulting stock concentration is 5.0 mg/mL (5,000 µg/mL).

To prepare a 10 µM working concentration in a 10 mL cell culture media assay:

1. Calculate the molar mass of KPV: 383.48 g/mol. 2. Determine stock molarity: A 5.0 mg/mL solution equals 13.038 mM (13,038 µM). 3. Apply C1V1 = C2V2: (13,038 µM) * (V1) = (10 µM) * (10,000 µL). 4. V1 = 7.67 µL of KPV stock solution diluted into 9.992 mL of culture medium.

Maintaining high concentration precision in stock preparation ensures consistent treatment parameters across cell culture plates and prevents vehicle-mediated osmolarity shifts during preclinical testing.

Comparative Analysis: KPV vs. Other Gut-Mucosal Research Compounds

When designing gut mucosal and anti-inflammatory research protocols, investigators often evaluate KPV alongside related signaling peptides. Comparative preclinical studies frequently examine KPV in conjunction with BPC-157 mechanism of action for cytoprotective pathway cross-talk, Larazotide acetate for tight-junction assembly regulation, and Vasoactive Intestinal Peptide (VIP) for neuro-immune modulation. While Larazotide primarily targets zonula occludens-1 (ZO-1) disassembly, KPV acts directly on intracellular NF-kB transcription factor translocation following PepT1-mediated cellular uptake.

Unlike larger polypeptide structures, KPV’s tripeptide configuration confers unique metabolic stability against proteolytic cleavage in tissue homogenates. This makes it an exceptionally versatile tool for comparative assays exploring epithelial repair and cytokine suppression.

Researchers seeking additional comparative datasets and chemical specifications can consult the PX1 Research library for technical whitepapers across our entire portfolio.

Quality Verification: HPLC, Mass Spectrometry, and Endotoxin Testing

Analytical rigor is crucial when evaluating research peptides for cellular or animal models. Minor impurities or leftover synthesis reagents (such as trifluoroacetic acid, TFA) can skew experimental data and induce non-specific cytotoxicity in delicate cell lines.

High-performance liquid chromatography (RP-HPLC) is used to verify peptide purity. PX1 Research requires that every lot of KPV exhibit a single, sharp chromatogram peak representing greater than 99% purity. Electrospray Ionization Mass Spectrometry (ESI-MS) further confirms exact molecular weight and structural identity.

Crucially, endotoxin contamination must be rigorously controlled. Gram-negative bacterial endotoxins (lipopolysaccharides) alter inflammatory signaling and obscure KPV’s intrinsic anti-inflammatory properties in colitis models. PX1 Research tests every lot using chromogenic LAL assays to ensure endotoxin levels fall strictly below <0.01 EU/mg.

PX1 Research Standards: Sourcing High-Purity Research Compounds

PX1 Research serves as a trusted primary supplier for university laboratories, private research institutions, and contract research organizations worldwide. All peptides are manufactured in US-based, GMP-compliant facilities operating under strict ISO 17025 laboratory quality control standards.

Every batch of lyophilized peptide undergoes independent third-party laboratory verification before release. Each product page includes direct access to a lot-specific Certificate of Analysis (COA) detailing RP-HPLC purity profiles, mass spectrometry verification, and endotoxin assay results.

Orders are dispatched same-day (Monday through Friday) from our centralized CA and AZ fulfillment centers to prevent thermal degradation during transit. Qualified academic and industrial facilities can establish a wholesale research account for bulk procurement and ongoing study supply.